Community Academy Public Charter School, DC 'BBB-' Bond Rating Placed On Watch Neg On Potential Charter Revocation Dec 11

  • ID: 2036096
  • December 2011
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Dec. 30, 2011--Standard & Poor's Ratings Services has placed the 'BBB-' rating on the District of Columbia's series 2007 tax-exempt fixed-rate revenue bonds, issued for Community Academy Public Charter School on CreditWatch with negative implications. The rating reflects Standard & Poor's opinion of the Dec. 21, 2011 announcement by the D.C. Public Charter School Board (PSCB) that it approved a proposal to revoke the charter of the school due to the poor 2010-2011 academic performance of its Rand Campus based on recently enacted Performance Management Framework standards. "According to the school and the press release, the PSCB is considering the revocation of the charter based solely on the test scores of the Rand Campus," said...

Companies mentioned in this report are:
- Community Acad Pub Charter Sch
- District of Columbia

Action: On CreditWatch:Negative

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Community Acad Pub Charter Sch
- District of Columbia

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.